Se protéger du SIDA ? - L’exemple des singes d’Afrique

Béatrice Jacquelin; Olivier Rescanière; Anne-Sophie Liovat; Gaël Petitjean; Françoise Barré-Sinoussi; Michaela Müller-Trutwin

doi:10.1051/medsci/2010265461

Accueil

Tous les numéros

Volume 26 / Numéro 5 (Mai 2010)

Med Sci (Paris), 26 5 (2010) 461-463

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 26, Numéro 5, Mai 2010


Page(s)		461 - 463
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/2010265461
Publié en ligne		15 mai 2010

Peeters M, Chaix ML, Delaporte E. Phylogénie des SIV et des VIH. Mieux comprendre l’origine des VIH. Med Sci (Paris) 2008; 24 : 621–8. [Google Scholar]
Liovat AS, Jacquelin B, Ploquin MJ, et al. African non human primates infected by SIV - why don’t they get sick ? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr HIV Res 2009; 7 : 39–50. [Google Scholar]
Lozano Reina JM, Favre D, Kasakow Z, et al. Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2009; 83 : 2770–7. [Google Scholar]
Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15 : 861–5. [Google Scholar]
Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179 : 859–70. [Google Scholar]
Kornfeld C, Ploquin MJ, Pandrea I, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115 : 1082–91. [Google Scholar]
Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83 : 3719–33. [Google Scholar]
Diop OM, Ploquin MJ, Mortara L, et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008; 82 : 5145–52. [Google Scholar]
Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119 : 3544–55. [Google Scholar]
Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119 : 3556–72. [Google Scholar]
Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81 : 8838–42. [Google Scholar]
Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l’infection par le VIH ? Med Sci (Paris) 2008; 24 : 7–9. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Peeters M, Chaix ML, Delaporte E. Phylogénie des SIV et des VIH. Mieux comprendre l’origine des VIH. Med Sci (Paris) 2008; 24 : 621–8. [Google Scholar]

[2] Liovat AS, Jacquelin B, Ploquin MJ, et al. African non human primates infected by SIV - why don’t they get sick ? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr HIV Res 2009; 7 : 39–50. [Google Scholar]

[3] Lozano Reina JM, Favre D, Kasakow Z, et al. Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2009; 83 : 2770–7. [Google Scholar]

[4] Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15 : 861–5. [Google Scholar]

[5] Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179 : 859–70. [Google Scholar]

[6] Kornfeld C, Ploquin MJ, Pandrea I, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115 : 1082–91. [Google Scholar]

[7] Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83 : 3719–33. [Google Scholar]

[8] Diop OM, Ploquin MJ, Mortara L, et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008; 82 : 5145–52. [Google Scholar]

[9] Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119 : 3544–55. [Google Scholar]

[10] Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119 : 3556–72. [Google Scholar]

[11] Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81 : 8838–42. [Google Scholar]

[12] Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l’infection par le VIH ? Med Sci (Paris) 2008; 24 : 7–9. [Google Scholar]